RaySearch Laboratories AB (publ) Interim Report January 1 - March 31, 2004

• Net sales totaled SEK 10.1m (7.3) between January and March 2004
• Net profit was SEK 3.9m (2.8) during the period
• Earnings per share after tax reached SEK 0.37 (0.27)
• Operating profit totaled SEK 5.5m (3.9)
• Licensing agreement signed with Nucletron; customer base doubles
• Intensified focus on research and development
For more information, please contact:
Johan Löf
CEO, RaySearch Laboratories AB
Phone: +46 (0)8-545 061 30
 

RaySearch Laboratories

RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are sold through license agreements with leading partners su...

View more


  CONTACT  

Related documents

 
 
 
 
Social Media Pitch:
RaySearch Laboratories AB (publ) Interim Report January 1 - March 31, 2004